Wuxiyar Otkur
Shenyang Pharmaceutical University(CN)Dalian Institute of Chemical Physics(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Autophagy in Disease and Therapy, Silymarin and Mushroom Poisoning, Cancer, Lipids, and Metabolism, Acute Ischemic Stroke Management
Most-Cited Works
- → USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma(2022)168 cited
- → The roles of E3 ubiquitin ligases in cancer progression and targeted therapy(2023)157 cited
- → F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects(2020)93 cited
- → Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite‐Protein Interaction Network(2021)72 cited
- → YB1 regulates miR‐205/200b‐ ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma(2021)36 cited
- → Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers(2023)32 cited
- → Autophagy induced by silibinin protects human epidermoid carcinoma A431 cells from UVB-induced apoptosis(2013)31 cited
- → Silibinin protects murine fibroblast L929 cells from UVB‐induced apoptosis through the simultaneous inhibition of ATM‐p53 pathway and autophagy(2013)29 cited
- → Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway(2021)25 cited
- → Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex(2022)25 cited